help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on September 19, 2006
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-0777
A more recent version of this article appeared on December 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
91/12/4976    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grischuk, Y.
Right arrow Articles by Krone, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grischuk, Y.
Right arrow Articles by Krone, N.

Submitted on April 10, 2006
Accepted on September 8, 2006

Four novel missense mutations in the CYP21A2 gene detected in Russian patients suffering from the classical form of congenital adrenal hyperplasia (CAH): identification, functional characterization and structural analysis

Yulia Grischuk, Petr Rubtsov, Felix G. Riepe, Joachim Grötzinger, Svetlana Beljelarskaia, Vladimir Prassolov, Natalya Kalintchenko, Tatyana Semitcheva, Valentina Peterkova, Anatoly Tiulpakov, Wolfgang G. Sippell, and Nils Krone*

Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Ulitsa Vavilova, 32, 119991, Moscow, Russian Federation; Division of Pediatric Endocrinology, Department of Pediatrics, Christian-Albrechts-Universität zu Kiel, Universitätsklinikum Schleswig-Holstein (Campus Kiel), Schwanenweg 20, D-24105 Kiel, Germany; Biochemisches Institut, Christian-Albrechts-Universität zu Kiel, Olshausenstrasse 40, D-24098 Kiel, Germany; Institute of Pediatric Endocrinology, Endocrinological Research Center, Ulitsa Dmitriya Ulianova, 11, 117036, Moscow, Russian Federation

* To whom correspondence should be addressed. E-mail: krone{at}pediatrics.uni-kiel.de.

Context: Congenital adrenal hyperplasia is a group of autosomal recessive inherited disorders of steroidogenesis. The most frequent cause is the deficiency of steroid 21-hydroxylase (CYP21) due to mutations in the CYP21A2 gene.

Objective: We analyzed the functional and structural consequences of the four CYP21A2 missense mutations (C169R, G178R, W302R, and R426C) to prove their clinical relevance and study their impact on CYP21 function.

Results: Analyzing the mutations in vitro revealed an almost absent or negligible CYP21 activity for the conversion of 17-hydroxyprogesterone to 11-deoxycortisol and progesterone to deoxycorticosterone. Protein translation and intracellular localization were not affected by the mutants, as could be demonstrated by Western blotting and immunofluorescence studies. Analysis of these mutants in a 3-dimensional model structure of the CYP21 protein explained the observed in vitro effects, as all the mutations severely interfere either directly or indirectly with important structures of the 21-hydroxylase protein.

Conclusion: The in vitro expression analysis of residual enzyme function is a complementary method to genotyping and an important tool for improving the understanding of the clinical phenotype of 21-hydroxylase deficiency. This forms the foundation for accurate clinical and genetic counseling and for prenatal diagnosis and treatment. Moreover, this report demonstrates that the combination of in vitro enzyme analysis and molecular modeling can yield novel insights into CYP450 structure-functional relationships.


Key words: Congenital adrenal hyperplasia (CAH) • 21-hydroxylase deficiency • CYP21A2 gene • CYP21 • cytochrome P450 enzyme




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
M. Welzel, N. Wustemann, G. Simic-Schleicher, H. G. Dorr, E. Schulze, G. Shaikh, P. Clayton, J. Grotzinger, P.-M. Holterhus, and F. G. Riepe
Carboxyl-Terminal Mutations in 3{beta}-Hydroxysteroid Dehydrogenase Type II Cause Severe Salt-Wasting Congenital Adrenal Hyperplasia
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1418 - 1425.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society